Cargando…
Abatacept for the treatment of adults with psoriatic arthritis: patient selection and perspectives
Psoriatic arthritis (PsA) is a heterogeneous disease with several clinical subtypes including peripheral arthritis, dactylitis, enthesitis, nail disease, and axial arthritis. Nonsteroidal anti-inflammatory drugs, glucocorticoids, and conventional disease-modifying agents are used as first line in th...
Autores principales: | Noisette, Ashley, Hochberg, Marc C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047621/ https://www.ncbi.nlm.nih.gov/pubmed/30035098 http://dx.doi.org/10.2147/PTT.S146076 |
Ejemplares similares
-
Current treatment options for psoriatic arthritis: spotlight on abatacept
por: Ursini, Francesco, et al.
Publicado: (2018) -
Abatacept in psoriatic arthritis: Case report and short review
por: Ursini, Francesco, et al.
Publicado: (2013) -
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis
por: Szentpetery, Agnes, et al.
Publicado: (2017) -
Abatacept in the treatment of rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2008) -
Abatacept in the treatment of rheumatoid arthritis
por: Vital, Edward M, et al.
Publicado: (2006)